May 21, 2024 | By: Grady Wertman
This whitepaper focuses on the importance of disinfectant validations based on real-world conditions to maintain cGMP compliance in pharmaceutical manufacturing. It discusses the lack of specific testing requirements and the limitations of current testing methods and emphasizes the growing importance of site-specific surface testing.
Learn about the author below.
Study Director
Grady Wertman is an experienced microbiologist and study director with extensive background supporting sterility assurance and microbiological testing programs for medical device and pharmaceutical manufacturers. Grady is recognized for his strong technical foundation and detailed understanding of test methodologies, with a focus on ensuring studies are designed, executed, and documented to meet regulatory and client expectations. He holds undergraduate degrees in Cellular Biology/Neuroscience and Microbiology from Montana State University.
